JEFFREY J. KIMBELL & ASSOCIATES, INC.

Lobbying for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. · Pharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Connecticut · House · Senate · $40,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Health Issues

Issues related to diabetes and cardiovascular disease

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.